|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 4800 Deerwood Campus Parkway (DCC 2-2) |
Address2 |
|
| City | Jacksonville |
State | FL |
Zip Code | 32246 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 6382-12
|
||||||||
|
6. House ID# 314000000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Kelly James |
Date | 10/17/2024 1:04:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
ACA Subsidies and Tax Credits; Mental Health Care; Hospital Billing; Transparency in Coverage; Hospital Consolidation; Health Equity Index; Cybersecurity; Provider Directories; Artificial Intelligence; Health Equity; Health Care Fraud; Food as Medicine; Mental Health Parity
HR 1843, Telehealth Expansion Act, by Rep. Michelle Steel (R-CA). To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
HR 3120, Healthy Competition for Better Care Act, by Rep. Michelle Steel (R-CA). To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care.
HR 3226, PREEMIE Reauthorization Act of 2023, by Rep. Anna Eshoo (D-CA). Reauthorizes through FY2028 and otherwise modifies research and education programs for preventing premature births.
HR 3305, Black Maternal Health Momnibus Act, by Rep. Lauren Underwood (D-IL). To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States.
HR 3417, FAIR Act, by Rep. Kevin Hern (R-OK). To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
HR 3630, No Surprises Act, by Rep. Frank Pallone (D-NJ). To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices.
HR 3838, Preventing Maternal Deaths Reauthorization Act of 2023, by Rep. Michael Burgess (R-TX). To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers.
HR 4093, Remote Opioid Monitoring, by Rep. Troy Balderson (R-OH). To provide for a study on the effects of remote monitoring on individuals who are prescribed opioids.
HR 4189, CONNECT for Health Act, by Rep. Mike Thompson (D-CA). To amend title XVIII of the Social Security Act to expand access to telehealth services.
HR 4531, Support for Patients and Communities Reauthorization Act, by Rep. Brett Guthrie (R-KY). To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment.
HR 4581, Maternal and Child Health Stillbirth Prevention Act, by Rep. Ashley Hinson (R-IA). To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes.
HR 5012, SHINE for Autumn Act, by Rep. Young Kim (R-CA). To improve research and data collection on stillbirths.
HR 5066, Tech to Save Moms Act, by Rep. Nikema Williams (D-GA). To amend the Public Health Service Act to authorize grants to evaluate, develop, and expand the use of technology-enabled collaborative learning and capacity building models to improve maternal health outcomes, and for other purposes.
HR 5378, Lower Costs, More Transparency Act, by Rep. Cathy McMorris Rodgers (R-WA). To promote price transparency in the health care sector.
HR 6033, SPEAK Act, by Rep. Michelle Steel (R-CA). To require the Secretary of Health and Human Services to establish a task force to improve access to health care information technology for non-English speakers.
HR 6465, PLASMA Act, by Rep. Richard Hudson (R-NC). To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
HR 6487, No Fees for EFTs Act, by Rep. Gregory Murphy (R-NC). To amend title XI of the Social Security Act to prohibit health plans from imposing fees on health care providers for electronic funds transfers and health care payment and remittance advice transactions.
S 1869, SITE Act, by Sen. Mike Braun (D-HI). To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs.
S 2016, CONNECT for Health Act of 2023, by Sen. Brian Schatz (D-HI). To amend title XVIII of the Social Security Act to expand access to telehealth services.
S 2556, Improving CARE for Youth Act, by Sen. Thomas Carper (D-DE). To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
S 3393, SUPPORT for Patients and Communities Reauthorization Act, by Sen. Bernie Sanders (I-VT). To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes.
S 3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023, by Sen. Ron Wyden (D-OR). To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Labor - Dept of (DOL)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Giles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage (MA)
HR 4605, Healthy Moms and Babies Act, by Rep. Earl Carter (R-GA). To amend titles XIX and XXI of the Social Security Act to improve maternal health coverage under Medicaid and CHIP.
HR 4758, Accelerating Kids Access to Care Act, by Rep. Lori Trahan (D-MA). To amend title XIX of the Social Security Act to streamline enrollment under the Medicaid program of certain providers across State lines.
HR 5394, Expanding Remote Monitoring Access Act, by Rep. Troy Balderson (R-OH). To ensure appropriate access to remote monitoring services furnished under the Medicare Program.
HR 5746, Addressing Whole Health in Medicare Advantage Act, by Rep. Gus Bilirakis (R-FL). To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees.
HR 6860, Restore Protections for Dialysis Patients Act, by Rep. Mike Kelly (R-PA). To amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act.
HR 7149, Equal Access to Specialty Care Everywhere (EASE) Act of 2024, by Rep. Michelle Steel (R-CA). To amend title XI of the Social Security Act to require the Center for Medicare and Medicaid Innovation to test a model to improve access to specialty health services for certain Medicare and Medicaid beneficiaries.
HR 7623, Telehealth Modernization Act, by Rep. Earl Carter (R-GA). To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program.
HR 7996, Improving CARE for Youth Act, by Rep. Neal Dunn (R-FL). To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
HR 8532, Connected MOM Act, by Rep. Lois Frankel (D-FL). To identify and address barriers to coverage of remote physiologic devices under State Medicaid programs to improve maternal and child health outcomes for pregnant and postpartum women.
HR 8702, Improving Seniors Timely Access to Care Act of 2024, by Rep. Mike Kelly (R-PA). To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Giles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Gene Therapies; Prescription Drug Affordability
HR 6094, PROTECT Rare Act, by Rep. Doris Matsui (D-CA). To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition.
HR 9070, Affordable Prescriptions for Patients Act of 2024, by Rep. Darrell Issa (R-CA). To amend title 35, United States Code, to prohibit product hopping.
S 150, Affordable Prescriptions for Patients Act of 2023, by Sen. John Cornyn (R-TX). To amend the Federal Trade Commission Act to prohibit product hopping.
S 775, Increasing Transparency in Generic Drug Applications Act, by Sen. Margaret Hassan (D-NH). To provide for increased transparency in generic drug applications.
S 1542, DRUG Act, by Sen. Roger Marshall (R-KS). To improve services provided by pharmacy benefit managers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
Giles |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |